CVE-2015-3965: vulnerability in Hospira Symbiq Infusion System
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
3Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackepss 2.9%
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Affected products
Hospira · Symbiq Infusion SystemRelated CVEs — Hospira Symbiq Infusion System
In the same product, most dangerous first.